Menu Close

I am a health policy analyst and researcher at the Hilltop Institute at the University of Maryland-Baltimore County.

The goal of my research is to understand how payment systems and macro-level social and economic factors impact access to care, particularly access to medications, with a focus on vulnerable populations.

Most recently, I have been co-leading an initiative centered around increasing patient access to care though greater hospital price transparency.

I am a member of the International Society for Pharmacoepidemiology (ISPE), where I sit on the biosimilars/biologics Special Interest Group (SIG).


  • –present
    Policy Analyst, University of Maryland, Baltimore County